Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Challenging the notion of ‘entitled millennials,’ Rise Fast empowers young people
When the economy took a turn for the worst in 2008, many millennials saw their parents and grandparents laid off by companies they’d been loyal to for years. Eze Redwood said that although it’s easy to gloss over the impact that traumatic events have on a generation’s psyche, young professionals carry the weight of this…
As engagement grows, KC Women in Technology gears up for 2017
Imagine if the next Mark Zuckerberg was a young female living in Kansas City. Despite an interest and aptitude in technology, imagine she walks into a popular clothing store and seeing a shirt that reads: “I’m too pretty to do math.” Subliminal messages such as this are not an uncommon occurrence for many young women.…
KC programs become semifinalists in Harvard innovation contest
Harvard University has recognized two Kansas City initiatives as semifinalists in the school’s Innovations in American Government Awards competition. Led by the City of Kansas City, Mo., the Community Improvement District Revolving Loan Fund and Women’s Empowerment initiative both are among 100 programs vying for a shot to become finalists and the $100,000 grand prize.…
The Lean Lab continues to make an impact in KC education
As the Lean Lab looks back on its third year, co-founder Katie Boody said the program is “just getting started.” Launched in 2013, the Kansas City-based education tech incubator engaged over 900 individuals in conversation on education innovation in 2016. In addition, last year marked the organization’s first step to go international, attracting entrepreneurs that…